Literature DB >> 12747949

A novel tumour model system for the study of long-term protective immunity and immune T cell memory.

Yolanda D Mahnke1, Volker Schirrmacher.   

Abstract

We present a novel non-transgenic system to be used for studies on anti-tumour adoptive immunotherapy (ADI) and long-term T cell memory. Tumour-reactive donor immune cells against lacZ-transfected syngeneic tumour cells (ESbL-Gal) were generated from a naíve T cell repertoire in DBA/2 mice by a well-established priming/restimulation protocol, and transferred to tumour-inoculated athymic nu/nu mice. The donor immune cells efficiently mediated protective anti-tumour immunity involving both CD4(+) and CD8(+) T cells, and anti-metastatic effects were stronger in 4.5 Gy pre-irradiated than in non-irradiated tumour-inoculated hosts. Long-term persistence of beta-galactosidase (Gal)-specific T cells was shown ex vivo by tetramer staining of CD8(+) T cells specific for an immunodominant Gal epitope. Resistance of treated nu/nu mice against tumour rechallenge revealed the existence of long-term protective immune memory.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12747949     DOI: 10.1016/s0008-8749(03)00062-5

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  2 in total

1.  Maintenance of long-term tumour-specific T-cell memory by residual dormant tumour cells.

Authors:  Yolanda D Mahnke; Jochen Schwendemann; Philipp Beckhove; Volker Schirrmacher
Journal:  Immunology       Date:  2005-07       Impact factor: 7.397

Review 2.  New Insights into Mechanisms of Long-term Protective Anti-tumor Immunity Induced by Cancer Vaccines Modified by Virus Infection.

Authors:  Volker Schirrmacher
Journal:  Biomedicines       Date:  2020-03-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.